Additionally, with the growing demand for chronic disease treatments and the ageing baby boomer population, the infusion market is set for significant growth. According to the market research ...

A single infusion of liposomal amphotericin B was not inferior to a 15-dose regimen of amphotericin B deoxycholate. Despite impressive cure rates for several antileishmanial agents, lengthy ...